Tissue-Specific Targeting for Cardiovascular Gene Transfer. Potential Vectors and Future Challenges
Journal:
Current Gene Therapy
Volume:
4
Page:
457-467
Author(s):
Caroline Beck, Hidetaka Uramoto, Jan Boren and Levent M. Akyurek
Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
621-635
Author(s):
Ravi D. Rao, Jan C. Buckner and Jann N. Sarkaria
Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
653-671
Author(s):
Hue H. Luu, Ruiwen Zhang, Rex C. Haydon, Elizabeth Rayburn, Quan Kang, Weike Si, Jong Kyung Park, Hui Wang, Ying Peng, Wei Jiang and Tong- Chuan He
Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
689-702
Author(s):
P. Michl and T. M. Gress
Alpha-Interferon and Its Effects on Signalling Pathways Within Cells
Journal:
Current Protein & Peptide Science
Volume:
5
Page:
475-485
Author(s):
Michele Caraglia, Giovanni Vitale, Monica Marra, Alfredo Budillon, Pierosandro Tagliaferri and Alberto Abbruzzese
Nur77 Family of Nuclear Hormone Receptors
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
413-423
Author(s):
Hui -Chen Hsu, Tong Zhou and John D. Mountz
Closely Related Antiretroviral Agents as Inhibitors of Two HIV-1 Enzymes, Ribonuclease H and Integrase: “Killing Two Birds with One Stone”
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3713-3723
Author(s):
Marie-Line Andreola
Targeting the Assembly of the Human Immunodeficiency Virus Type I
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3725-3739
Author(s):
D. Muriaux, J. L. Darlix and A. Cimarelli
Killing the Messenger: Antisense DNA and siRNA
Journal:
Current Drug Targets
Volume:
5
Page:
683-689
Author(s):
M. Nesterova and Y. S. Cho-Chung
Extracellular Tropomyosin: A Novel Common Pathway Target for Anti- Angiogenic Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
543-553
Author(s):
Fernando Donate, Keith McCrae, David E. Shaw and Andrew P. Mazar